RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
RPTP was delisted on the 24th of October, 2016.
71 hedge funds and large institutions have $412M invested in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in 2013 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 32 increasing their positions, 16 reducing their positions, and 5 closing their positions.
200% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 5
108% more capital invested
Capital invested by funds: $198M → $412M (+$214M)
100% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 16
16% more funds holding
Funds holding: 61 → 71 (+10)
39% less call options, than puts
Call options by funds: $989K | Put options by funds: $1.62M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$35.6M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$15.2M |
| 3 |
State Street
Boston,
Massachusetts
|
+$12M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$5.37M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IA
Investor AB
Stockholm,
Sweden
|
-$14.4M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$2.58M |
| 3 |
UBS AM
Chicago,
Illinois
|
-$2.27M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$1.2M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$722K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Citadel Advisors
Miami,
Florida
| – | -$55.1K | -4,595 | Closed |
|
RPTP Hedge Fund Activity: Q3 2013 in Review
71 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) for Q3 2013, worth a combined $412M — up 108% from $198M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new RPTP positions and 5 closed out — a net gain of 10 holders — while 32 added to existing stakes and 16 trimmed.
The largest buyer was Royal Bank of Canada, opening a new position worth an estimated $35.6M. The largest seller was Investor AB, exiting entirely with an estimated $14.4M sold.
- 71 institutional investors held RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) as of Q3 2013, up from 61 in Q2 2013.
- Funds reported $412M of RAPTOR PHARMACEUTICAL CORP COM STK (DE) stock for Q3 2013, up 108% quarter-over-quarter.
- 15 funds opened new RAPTOR PHARMACEUTICAL CORP COM STK (DE) positions in Q3 2013 and 5 closed out, a net change of +10 holders.
- The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) buyer in Q3 2013 was Royal Bank of Canada, an estimated $35.6M added.
- The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) seller in Q3 2013 was Investor AB, an estimated $14.4M sold.
Based on aggregated 13F filings for Q3 2013.